Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

BlackRock Health Sciences Opportunities Portfolio

+ Add to Watchlist

BHSRX:US

54.84 USD 0.47 0.85%

As of 09:29:30 ET on 04/17/2015.

Snapshot for BlackRock Health Sciences Opportunities Portfolio (BHSRX)

Year To Date: +11.99% 3-Month: +8.74% 3-Year: +31.21% 52-Week Range: 38.94 - 55.82
1-Month: +0.49% 1-Year: +42.37% 5-Year: - Beta vs SPX: 0.95

Mutual Fund Chart for BHSRX

No chart data available.
  • BHSRX:US 54.84
  • 1M
  • 1Y
Interactive BHSRX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for BHSRX

BlackRock Health Sciences Opportunities Portfolio is an open-end fund incorporated in the USA. The Fund's objective is long-term growth of capital. The Fund normally invests at least 80% of total assets in securities of companies in health sciences and related industries.

Inception Date: 09-12-2011 Telephone: 1-800-441-7762
Managers: THOMAS P CALLAN / ERIN XIE
Web Site: www.blackrock.com

Fundamentals for BHSRX

NAV (on 2015-04-17) 54.84
Assets (M) (on 2015-04-17) 5,769.39
Fund Leveraged N
Minimum Investment 100.00
Minimum Subsequent Investment 0.00

Dividends for BHSRX

Dividend Type Short Term Cap Gain
Dividend Frequency Irreg
Last Dividend Net (on 2014-12-12) 1.65
Dividend Yield (ttm) 6.14

Fees & Expenses for BHSRX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.70
Redemption Fee 0.00
12b1 Fee 0.50
Expense Ratio 1.49

Top Fund Holdings for BHSRX

Filing Date: 02/27/2015
Name Position Value % of Total
Celgene Corp 1,645,838 200,018,692 3.726%
Biogen Inc 468,512 191,897,830 3.574%
Actavis plc 570,846 166,321,691 3.098%
UnitedHealth Group Inc 1,432,194 162,740,204 3.031%
Medtronic PLC 2,084,323 161,722,637 3.012%
Amgen Inc 927,310 146,255,333 2.724%
McKesson Corp 615,600 140,787,720 2.622%
Alexion Pharmaceuticals Inc 751,517 135,551,121 2.525%
Abbott Laboratories 2,657,300 125,876,301 2.345%
Bristol-Myers Squibb Co 1,979,400 120,585,048 2.246%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil